High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.
about
Activity of Sorafenib against desmoid tumor/deep fibromatosisMusculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniquesImaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in developmentPhase II study on lapatinib in advanced EGFR-positive chordoma.Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications.Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcomaMolecularly targeted therapy using bevacizumab for non-small cell lung cancer: a pilot study for the new CT response criteriaPhase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas.Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience.Diffusion MRI and novel texture analysis in osteosarcoma xenotransplants predicts response to anti-checkpoint therapyTherapeutic response in musculoskeletal soft tissue sarcomas: evaluation by MRI.Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendotheliomaTNF-alpha and melphalan-based isolated limb perfusion: no evidence supporting the early destruction of tumour vasculatureCT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma.Viable tumor volume: Volume of interest within segmented metastatic lesions, a pilot study of proposed computed tomography response criteria for urothelial cancer.Personalized tumor response assessment in the era of molecular medicine: cancer-specific and therapy-specific response criteria to complement pitfalls of RECISTMalignant epithelioid hemangioendothelioma of the liver successfully treated with Sorafenib.Intra- and inter-observer variability in measurement of target lesions: implication on response evaluation according to RECIST 1.1.Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS).Long-term response to first-line trabectedin in an elderly female patient with a metastatic leiomyosarcoma unfit for anthracycline.Molecular targeted therapies in non-GIST soft tissue sarcomas: what the radiologist needs to knowNew medical treatment options and strategies to assess clinical outcome in soft-tissue sarcoma.The benefit of using CT-perfusion imaging for reliable response monitoring in patients with gastrointestinal stromal tumor (GIST) undergoing treatment with novel targeted agents.The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma.Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.The safety and efficacy of trabectedin for the treatment of liposarcoma or leiomyosarcoma.Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas.Molecular targeted therapy in gynaecologic malignancies: primer for radiologists.Desmoid fibromatosis: MRI features of response to systemic therapy.Pharmacological therapies for Liposarcoma.Anti-angiogenesis target therapy for advanced osteosarcoma (Review).Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy.Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard.Semi-automated volumetric quantification of tumor necrosis in soft tissue sarcoma using contrast-enhanced MRI.Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcoma.Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall.Tumor size increase following preoperative radiation of soft tissue sarcomas does not affect prognosis.Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor.
P2860
Q24620775-CF774F1A-D34A-4681-ACE4-BC55C7298CCFQ26828595-A5112619-CBB5-4006-AFB2-4F613148D128Q28083433-2B778103-6246-46AF-BF35-F0A9B4EDB393Q33274760-D0FA21F3-FED0-4EE8-AA69-D2A6EBB937A0Q33757142-BAA19927-DE3A-4C58-9D9C-F3128A8DA1ADQ34138698-B2CFCC32-FC8C-448F-9AEB-B7FFE4448FAEQ34280715-BA7C6CB1-0D8C-417E-9238-D974AFC24243Q34491021-2FC81E4A-14DF-4B1C-A83E-B59FB77734A5Q35060225-BEB7559B-86A1-4124-8D51-D160935E0A07Q35072927-5005FB85-046A-4E0A-9232-E00796651FA0Q35148900-661C87F8-18D3-4E9C-840B-FBB9EB90F0ABQ35596814-F751D7EB-7682-4BC8-BB7A-34A5B343C2DCQ35690539-9B767475-AEE0-427D-AB10-3D4E3AFA8DA8Q35776891-2F7267B9-BF36-4FF9-BBA7-6BE3039848FFQ35957992-083C8BCD-99F4-4798-9319-C8806A12B310Q35984183-7E6B2FA6-64B9-4EFC-A15E-A606A6C50F5CQ36015295-CD53E18F-13C6-4449-8D22-E9128C367C36Q36106229-B8903D0B-2F50-4E1C-B233-7F7949EA5829Q36177866-B127A372-FB4A-46E7-8ED8-256B41BDB73AQ36472317-D869F8BE-A9A9-4097-A6B7-094C13EED876Q36530034-92B41E55-6653-4D67-AEE8-D6D5F04ADD4CQ36819466-1CE8C272-353F-4C94-80A9-A11BD802FFF5Q37577930-4FE35EA1-D011-43A7-823C-17E6C249E26BQ38114042-3D3739E6-D787-49C5-8BC2-7492A6DA2F2CQ38263394-5439DF7D-D5C7-4D5B-93D5-C4918AFD96E2Q38375349-79F06A2C-AF94-4F6B-B556-0DBBF5F74F8AQ38386665-86FB6672-094A-4336-A0EF-D2FEF5E0ED0EQ38797843-19FC81F9-D801-4D3C-9C64-317433D01058Q38840133-FEA82BE5-6073-4246-817E-3F8EB751EB1CQ38849896-4DECE339-17B5-4EA0-8CBC-EC5AE470B28DQ38922228-08B76DA0-9A7E-4B20-A297-C12E1F246AA5Q38991731-CED0A02E-59D7-4E73-A644-8349252F0EA1Q39401628-5C947561-623C-4CDF-8D81-98E23A25AAB4Q41042295-2CECB78B-BCAA-42D3-82CB-3F0BADC9E685Q41717674-62783AD2-7B7F-4E19-9110-3D995763A07BQ41810446-B2E737D9-BEA9-4A99-87B4-B6FD983CBA23Q41963479-1359947A-6559-4A38-8473-D1AC191896B5Q44382222-5BFED290-2A43-41C8-A4B1-7B1E5530542CQ47255141-DAAF002D-0561-4DFB-8653-14BEAC1B3F44Q47274504-6FD98C95-C997-4278-89C8-D5A1DD06FAEB
P2860
High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
High-grade soft-tissue sarcoma ...... sing RECIST and Choi criteria.
@en
High-grade soft-tissue sarcoma ...... sing RECIST and Choi criteria.
@nl
type
label
High-grade soft-tissue sarcoma ...... sing RECIST and Choi criteria.
@en
High-grade soft-tissue sarcoma ...... sing RECIST and Choi criteria.
@nl
prefLabel
High-grade soft-tissue sarcoma ...... sing RECIST and Choi criteria.
@en
High-grade soft-tissue sarcoma ...... sing RECIST and Choi criteria.
@nl
P2093
P50
P1433
P1476
High-grade soft-tissue sarcoma ...... sing RECIST and Choi criteria.
@en
P2093
Antonella Messina
Claudio Piovesan
Palma Dileo
Valter Torri
P304
P356
10.1148/RADIOL.2512081403
P407
P50
P577
2009-03-04T00:00:00Z